Glickman Mark A
SEC CIK 1441461 · EDGAR
BoughtSold
Most active insiders at BSEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | UNGRODT JODI | Dir | — | — |
| 2 | SONENREICH STEVEN D | Dir | — | — |
| 3 | HASSETT BARRY | Chief Commercial Off | — | — |
| 4 | FORTUNATO MICHAEL A | CAO | — | — |
| 5 | WARRINGTON KENNETH HOWARD JR | Dir | — | — |
| 6 | SMITH-VAN VURST ANDREW | COO, Dir, 10% | — | — |
| 7 | POE BRANDON | CFO | — | — |
| 8 | LESSER HANNAWAY RAYNA | Dir | — | — |
| 9 | Matuszewski Jason | CEO, Dir, 10% | — | — |
| 10 | Glickman Mark A | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-28 16:15 | 2026-08-27 | BSEM | BioStem Technologies, Inc. | Glickman Mark A | Dir | M - OptEx | $0.00 | +7,671 | 7,671 | New | $0 |
| 2026-06-08 18:29 | 2026-06-08 | MTVA | MetaVia Inc. | Glickman Mark A | Dir | A - Grant | $0.00 | +17.2K | 20.6K | +499% | $0 | |
| 2025-07-01 | 2025-06-30 | MTVA | MetaVia Inc. | Glickman Mark A | Dir | A - Grant | $0.00 | +28.1K | 37.9K | +289% | $0 | |
| 2024-06-07 | 2024-06-07 | MTVA | MetaVia Inc. | Glickman Mark A | Dir | A - Grant | $0.00 | +5,051 | 9,740 | +108% | $0 | |
| M | 2023-07-28 | 2023-07-27 | MTVA | MetaVia Inc. | Glickman Mark A | Dir | A - Grant | $0.00 | +37.5K | 25.0K | New | $0 |
| D | 2022-12-09 | 2022-12-06 | TXMD | TherapeuticsMD, Inc. | Glickman Mark A | Co-CEO | S - Sale+OE | $4.92 | -440 | 1,294 | -25% | -$2,165 |
| D | 2022-12-09 | 2022-12-06 | TXMD | TherapeuticsMD, Inc. | Glickman Mark A | Co-CEO | M - OptEx | $0.00 | +1,734 | 1,734 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations